| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 4.18e-09 | 15 | 28 | 4 | GO:0005005 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.18e-08 | 19 | 28 | 4 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.90e-08 | 65 | 28 | 5 | GO:0004714 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.13e-07 | 85 | 28 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.62e-06 | 145 | 28 | 5 | GO:0004713 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 6.23e-05 | 1353 | 28 | 9 | GO:0004888 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 9.05e-05 | 171 | 28 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.46e-04 | 13 | 28 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.56e-04 | 1180 | 28 | 8 | GO:0022857 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.66e-04 | 664 | 28 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | transporter activity | 2.86e-04 | 1289 | 28 | 8 | GO:0005215 | |
| GeneOntologyMolecularFunction | lipid binding | 3.37e-04 | 988 | 28 | 7 | GO:0008289 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.23e-04 | 465 | 28 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | ATPase binding | 4.57e-04 | 108 | 28 | 3 | GO:0051117 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.40e-04 | 758 | 28 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.85e-04 | 793 | 28 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.72e-04 | 140 | 28 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | symporter activity | 1.19e-03 | 150 | 28 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.26e-03 | 343 | 28 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.33e-03 | 156 | 28 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.33e-03 | 600 | 28 | 5 | GO:0004672 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 1.62e-03 | 627 | 28 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 1.64e-03 | 938 | 28 | 6 | GO:0016772 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.32e-03 | 51 | 28 | 2 | GO:0140303 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.44e-03 | 193 | 28 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.58e-03 | 197 | 28 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.77e-03 | 709 | 28 | 5 | GO:0016773 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.64e-03 | 459 | 28 | 4 | GO:0005216 | |
| GeneOntologyMolecularFunction | kinase activity | 3.82e-03 | 764 | 28 | 5 | GO:0016301 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.85e-03 | 227 | 28 | 3 | GO:0051015 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.18e-03 | 477 | 28 | 4 | GO:0022804 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 4.81e-03 | 74 | 28 | 2 | GO:0005548 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.74e-03 | 81 | 28 | 2 | GO:0015370 | |
| GeneOntologyMolecularFunction | channel activity | 5.86e-03 | 525 | 28 | 4 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.90e-03 | 526 | 28 | 4 | GO:0022803 | |
| GeneOntologyMolecularFunction | virus receptor activity | 6.30e-03 | 85 | 28 | 2 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 6.44e-03 | 86 | 28 | 2 | GO:0140272 | |
| GeneOntologyMolecularFunction | phospholipid binding | 6.81e-03 | 548 | 28 | 4 | GO:0005543 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 8.03e-03 | 296 | 28 | 3 | GO:0015291 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 8.41e-03 | 301 | 28 | 3 | GO:0022853 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 8.96e-03 | 102 | 28 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | hormone binding | 9.13e-03 | 103 | 28 | 2 | GO:0042562 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.11e-02 | 334 | 28 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.20e-02 | 119 | 28 | 2 | GO:0015294 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.22e-02 | 120 | 28 | 2 | GO:0008013 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.40e-02 | 129 | 28 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | steroid binding | 1.49e-02 | 133 | 28 | 2 | GO:0005496 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 7.04e-07 | 54 | 27 | 4 | GO:0048013 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 EPHB6 GRIN2B WDFY3 EPHA6 SLC24A1 SV2A AR HCN1 SPTBN2 EPHA7 | 2.34e-07 | 1228 | 28 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | glutamatergic synapse | 8.15e-06 | 817 | 28 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | neuronal cell body | 9.56e-06 | 835 | 28 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | dendrite | 1.17e-05 | 858 | 28 | 8 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.19e-05 | 860 | 28 | 8 | GO:0097447 | |
| GeneOntologyCellularComponent | cell body | 2.07e-05 | 929 | 28 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | cell surface | 7.43e-05 | 1111 | 28 | 8 | GO:0009986 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 9.73e-05 | 67 | 28 | 3 | GO:0098686 | |
| GeneOntologyCellularComponent | apical dendrite | 8.37e-04 | 32 | 28 | 2 | GO:0097440 | |
| GeneOntologyCellularComponent | presynaptic active zone | 8.70e-04 | 141 | 28 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.51e-03 | 43 | 28 | 2 | GO:0098688 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.65e-03 | 45 | 28 | 2 | GO:0008328 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.97e-03 | 405 | 28 | 4 | GO:0045211 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.04e-03 | 50 | 28 | 2 | GO:0098878 | |
| GeneOntologyCellularComponent | cell projection membrane | 2.47e-03 | 431 | 28 | 4 | GO:0031253 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.53e-03 | 785 | 28 | 5 | GO:0098797 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 4.88e-03 | 78 | 28 | 2 | GO:0048787 | |
| GeneOntologyCellularComponent | brush border membrane | 5.51e-03 | 83 | 28 | 2 | GO:0031526 | |
| GeneOntologyCellularComponent | presynapse | 5.90e-03 | 886 | 28 | 5 | GO:0098793 | |
| GeneOntologyCellularComponent | presynaptic membrane | 5.90e-03 | 277 | 28 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | axon | 6.04e-03 | 891 | 28 | 5 | GO:0030424 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 6.43e-03 | 1293 | 28 | 6 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 6.57e-03 | 1299 | 28 | 6 | GO:0098827 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 6.86e-03 | 93 | 28 | 2 | GO:0030864 | |
| GeneOntologyCellularComponent | receptor complex | 7.12e-03 | 581 | 28 | 4 | GO:0043235 | |
| GeneOntologyCellularComponent | synaptic membrane | 7.20e-03 | 583 | 28 | 4 | GO:0097060 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 7.28e-03 | 1327 | 28 | 6 | GO:0042175 | |
| GeneOntologyCellularComponent | synaptic vesicle | 7.35e-03 | 300 | 28 | 3 | GO:0008021 | |
| GeneOntologyCellularComponent | cell-cell junction | 7.55e-03 | 591 | 28 | 4 | GO:0005911 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 8.77e-03 | 320 | 28 | 3 | GO:0016323 | |
| GeneOntologyCellularComponent | exocytic vesicle | 8.77e-03 | 320 | 28 | 3 | GO:0070382 | |
| GeneOntologyCellularComponent | anchoring junction | 8.81e-03 | 976 | 28 | 5 | GO:0070161 | |
| GeneOntologyCellularComponent | excitatory synapse | 9.00e-03 | 107 | 28 | 2 | GO:0060076 | |
| GeneOntologyCellularComponent | neuromuscular junction | 9.82e-03 | 112 | 28 | 2 | GO:0031594 | |
| GeneOntologyCellularComponent | postsynapse | 1.05e-02 | 1018 | 28 | 5 | GO:0098794 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.12e-02 | 350 | 28 | 3 | GO:0098802 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.15e-02 | 354 | 28 | 3 | GO:0009925 | |
| GeneOntologyCellularComponent | PML body | 1.21e-02 | 125 | 28 | 2 | GO:0016605 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 1.29e-02 | 129 | 28 | 2 | GO:0030863 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 1.36e-02 | 133 | 28 | 2 | GO:0005881 | |
| GeneOntologyCellularComponent | basal part of cell | 1.37e-02 | 378 | 28 | 3 | GO:0045178 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.37e-02 | 378 | 28 | 3 | GO:0034702 | |
| GeneOntologyCellularComponent | brush border | 1.75e-02 | 152 | 28 | 2 | GO:0005903 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.00e-09 | 14 | 28 | 4 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.00e-09 | 14 | 28 | 4 | PS00790 | |
| Domain | EphA2_TM | 4.00e-09 | 14 | 28 | 4 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.00e-09 | 14 | 28 | 4 | IPR016257 | |
| Domain | Eph_TM | 4.00e-09 | 14 | 28 | 4 | IPR027936 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.00e-09 | 14 | 28 | 4 | IPR001090 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.00e-09 | 14 | 28 | 4 | IPR001426 | |
| Domain | EPH_LBD | 4.00e-09 | 14 | 28 | 4 | PS51550 | |
| Domain | EPH_lbd | 4.00e-09 | 14 | 28 | 4 | SM00615 | |
| Domain | Ephrin_lbd | 4.00e-09 | 14 | 28 | 4 | PF01404 | |
| Domain | Ephrin_rec_like | 5.00e-08 | 25 | 28 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 5.00e-08 | 25 | 28 | 4 | IPR011641 | |
| Domain | SAM | 1.87e-07 | 88 | 28 | 5 | SM00454 | |
| Domain | SAM_DOMAIN | 2.74e-07 | 95 | 28 | 5 | PS50105 | |
| Domain | SAM | 3.04e-07 | 97 | 28 | 5 | IPR001660 | |
| Domain | - | 4.74e-07 | 106 | 28 | 5 | 1.10.150.50 | |
| Domain | Ephrin_rec_like | 4.94e-07 | 11 | 28 | 3 | PF07699 | |
| Domain | SAM/pointed | 7.75e-07 | 117 | 28 | 5 | IPR013761 | |
| Domain | Pkinase_Tyr | 1.26e-06 | 129 | 28 | 5 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.76e-06 | 138 | 28 | 5 | IPR001245 | |
| Domain | SAM_1 | 3.08e-06 | 68 | 28 | 4 | PF00536 | |
| Domain | Growth_fac_rcpt_ | 3.21e-06 | 156 | 28 | 5 | IPR009030 | |
| Domain | - | 4.10e-06 | 73 | 28 | 4 | 2.60.120.260 | |
| Domain | TyrKc | 8.64e-06 | 88 | 28 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 8.64e-06 | 88 | 28 | 4 | IPR020635 | |
| Domain | Galactose-bd-like | 1.12e-05 | 94 | 28 | 4 | IPR008979 | |
| Domain | PROTEIN_KINASE_TYR | 1.27e-05 | 97 | 28 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.27e-05 | 97 | 28 | 4 | IPR008266 | |
| Domain | SAM_2 | 3.58e-05 | 43 | 28 | 3 | PF07647 | |
| Domain | fn3 | 9.49e-05 | 162 | 28 | 4 | PF00041 | |
| Domain | FN3 | 1.58e-04 | 185 | 28 | 4 | SM00060 | |
| Domain | FN3 | 2.10e-04 | 199 | 28 | 4 | PS50853 | |
| Domain | FN3_dom | 2.53e-04 | 209 | 28 | 4 | IPR003961 | |
| Domain | MAGE_N | 4.05e-04 | 20 | 28 | 2 | SM01392 | |
| Domain | MAGE_N | 4.91e-04 | 22 | 28 | 2 | PF12440 | |
| Domain | MAGE_N | 4.91e-04 | 22 | 28 | 2 | IPR021072 | |
| Domain | Prot_kinase_dom | 7.20e-04 | 489 | 28 | 5 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 7.47e-04 | 493 | 28 | 5 | PS50011 | |
| Domain | Kinase-like_dom | 1.14e-03 | 542 | 28 | 5 | IPR011009 | |
| Domain | MAGE | 1.18e-03 | 34 | 28 | 2 | SM01373 | |
| Domain | MAGE | 1.32e-03 | 36 | 28 | 2 | PS50838 | |
| Domain | MHD_dom | 1.32e-03 | 36 | 28 | 2 | IPR002190 | |
| Domain | MAGE | 1.32e-03 | 36 | 28 | 2 | PF01454 | |
| Domain | Protein_kinase_ATP_BS | 2.32e-03 | 379 | 28 | 4 | IPR017441 | |
| Domain | PROTEIN_KINASE_ATP | 4.62e-03 | 459 | 28 | 4 | PS00107 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 3.44e-07 | 34 | 25 | 4 | MM15025 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 5.08e-07 | 92 | 25 | 5 | M27201 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.82e-06 | 51 | 25 | 4 | M27311 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 4.84e-06 | 65 | 25 | 4 | MM14911 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 5.01e-06 | 261 | 25 | 6 | MM15676 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.92e-05 | 502 | 25 | 7 | MM14537 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.58e-05 | 575 | 25 | 7 | M29853 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 5.40e-05 | 42 | 25 | 3 | M27308 | |
| Pathway | KEGG_AXON_GUIDANCE | 7.29e-05 | 129 | 25 | 4 | M5539 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.54e-04 | 18 | 25 | 2 | MM15023 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 4.54e-04 | 18 | 25 | 2 | MM15024 | |
| Pathway | REACTOME_EPHRIN_SIGNALING | 5.07e-04 | 19 | 25 | 2 | M27310 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 7.94e-10 | 17 | 28 | 4 | 12217323 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 1.29e-09 | 19 | 28 | 4 | 12684176 | |
| Pubmed | 1.99e-09 | 21 | 28 | 4 | 9267020 | ||
| Pubmed | 1.99e-09 | 21 | 28 | 4 | 11128993 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.99e-09 | 21 | 28 | 4 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.99e-09 | 21 | 28 | 4 | 20112066 | |
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.99e-09 | 21 | 28 | 4 | 10730216 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 2.94e-09 | 23 | 28 | 4 | 19542359 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 3.53e-09 | 24 | 28 | 4 | 16446123 | |
| Pubmed | 6.45e-09 | 83 | 28 | 5 | 11114734 | ||
| Pubmed | 3.65e-08 | 117 | 28 | 5 | 17145500 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 3.68e-08 | 42 | 28 | 4 | 11439183 | |
| Pubmed | 3.91e-08 | 9 | 28 | 3 | 9707552 | ||
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 5.59e-08 | 10 | 28 | 3 | 17304517 | |
| Pubmed | 7.68e-08 | 11 | 28 | 3 | 22065784 | ||
| Pubmed | 8.18e-08 | 51 | 28 | 4 | 19769959 | ||
| Pubmed | 1.03e-07 | 54 | 28 | 4 | 36237976 | ||
| Pubmed | 2.60e-07 | 16 | 28 | 3 | 8755474 | ||
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 5.28e-07 | 20 | 28 | 3 | 11256076 | |
| Pubmed | 5.28e-07 | 20 | 28 | 3 | 10207129 | ||
| Pubmed | 5.28e-07 | 20 | 28 | 3 | 9530499 | ||
| Pubmed | 5.28e-07 | 20 | 28 | 3 | 9576626 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 12534934 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 26204818 | ||
| Pubmed | Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors. | 6.25e-07 | 2 | 28 | 2 | 11799243 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15288768 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 18358509 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 15305378 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 18374401 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31566139 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 28358367 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 23333872 | ||
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 8.19e-07 | 23 | 28 | 3 | 25480914 | |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 9.00e-07 | 420 | 28 | 6 | 28065597 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 19491261 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 32858191 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 30298963 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 34232601 | ||
| Pubmed | The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer. | 1.87e-06 | 3 | 28 | 2 | 30134822 | |
| Pubmed | Androgen receptor, EGFR, and BRCA1 as biomarkers in triple-negative breast cancer: a meta-analysis. | 1.87e-06 | 3 | 28 | 2 | 25695063 | |
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 2.51e-06 | 33 | 28 | 3 | 26830346 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 19794963 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21737611 | ||
| Pubmed | Hippocampal Lnx1-NMDAR multiprotein complex mediates initial social memory. | 3.75e-06 | 4 | 28 | 2 | 31772302 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 24553861 | ||
| Pubmed | cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases. | 3.75e-06 | 4 | 28 | 2 | 7898931 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 17242169 | ||
| Pubmed | 4.53e-06 | 40 | 28 | 3 | 30898150 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 21935409 | ||
| Pubmed | Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk. | 6.24e-06 | 5 | 28 | 2 | 10932185 | |
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 17655843 | ||
| Pubmed | 9.36e-06 | 6 | 28 | 2 | 15996548 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 17686994 | ||
| Pubmed | Abnormal phospholipid composition impairs HDL biogenesis and maturation in mice lacking Abca1. | 1.31e-05 | 7 | 28 | 2 | 12859204 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 22229870 | ||
| Pubmed | PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. | 1.31e-05 | 7 | 28 | 2 | 9883737 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 21664258 | ||
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 7736574 | ||
| Pubmed | Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice. | 1.31e-05 | 7 | 28 | 2 | 36897941 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 1.64e-05 | 697 | 28 | 6 | 28298427 | |
| Pubmed | Mistargeting hippocampal axons by expression of a truncated Eph receptor. | 1.74e-05 | 8 | 28 | 2 | 12124402 | |
| Pubmed | EphB3 marks delaminating endocrine progenitor cells in the developing pancreas. | 1.74e-05 | 8 | 28 | 2 | 22434763 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 23326536 | ||
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 10774725 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 20838624 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 11403717 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 11580899 | ||
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 25073978 | ||
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 28197551 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 2.80e-05 | 10 | 28 | 2 | 16547242 | |
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 2.80e-05 | 10 | 28 | 2 | 22021100 | |
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 11493560 | ||
| Pubmed | Quantitative assessment of computational models for retinotopic map formation. | 2.80e-05 | 10 | 28 | 2 | 25367067 | |
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 2.80e-05 | 10 | 28 | 2 | 10839360 | |
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 10559410 | ||
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 4.10e-05 | 12 | 28 | 2 | 21465626 | |
| Pubmed | 4.33e-05 | 496 | 28 | 5 | 31343991 | ||
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 20513444 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 4.85e-05 | 13 | 28 | 2 | 15117747 | |
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 4.85e-05 | 13 | 28 | 2 | 17039519 | |
| Pubmed | 4.85e-05 | 13 | 28 | 2 | 12528186 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 5.41e-05 | 91 | 28 | 3 | 28558017 | |
| Pubmed | 5.65e-05 | 14 | 28 | 2 | 26941654 | ||
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 5.65e-05 | 14 | 28 | 2 | 11222144 | |
| Pubmed | Overexpression of RhoH Permits to Bypass the Pre-TCR Checkpoint. | 5.65e-05 | 14 | 28 | 2 | 26114424 | |
| Pubmed | 7.45e-05 | 16 | 28 | 2 | 38429579 | ||
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 8.44e-05 | 17 | 28 | 2 | 12971893 | |
| Pubmed | Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. | 8.44e-05 | 17 | 28 | 2 | 24441682 | |
| Pubmed | 1.06e-04 | 19 | 28 | 2 | 35294885 | ||
| Pubmed | 1.30e-04 | 21 | 28 | 2 | 31577955 | ||
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 1.56e-04 | 23 | 28 | 2 | 24360543 | |
| Pubmed | 1.56e-04 | 23 | 28 | 2 | 19571816 | ||
| Pubmed | 1.71e-04 | 24 | 28 | 2 | 36718792 | ||
| Pubmed | Elimination of the male reproductive tract in the female embryo is promoted by COUP-TFII in mice. | 1.71e-04 | 24 | 28 | 2 | 28818950 | |
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 1.85e-04 | 25 | 28 | 2 | 8493579 | |
| Pubmed | Yap and Taz are required for Ret-dependent urinary tract morphogenesis. | 2.86e-04 | 31 | 28 | 2 | 26243870 | |
| Pubmed | 2.92e-04 | 403 | 28 | 4 | 30562941 | ||
| Pubmed | 3.25e-04 | 33 | 28 | 2 | 31143371 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 3.31e-04 | 1203 | 28 | 6 | 29180619 | |
| Pubmed | 5.53e-04 | 43 | 28 | 2 | 21116278 | ||
| Interaction | SEC23B interactions | 5.14e-07 | 222 | 28 | 6 | int:SEC23B | |
| Interaction | LIN7C interactions | 5.82e-07 | 119 | 28 | 5 | int:LIN7C | |
| Interaction | CLDN4 interactions | 3.21e-06 | 74 | 28 | 4 | int:CLDN4 | |
| Interaction | DUSP18 interactions | 4.77e-06 | 24 | 28 | 3 | int:DUSP18 | |
| Interaction | SEPTIN8 interactions | 6.13e-06 | 87 | 28 | 4 | int:SEPTIN8 | |
| Interaction | SEPTIN6 interactions | 6.41e-06 | 88 | 28 | 4 | int:SEPTIN6 | |
| Interaction | EPHB2 interactions | 1.09e-05 | 216 | 28 | 5 | int:EPHB2 | |
| Interaction | TNIK interactions | 1.16e-05 | 381 | 28 | 6 | int:TNIK | |
| Interaction | EFNA1 interactions | 1.20e-05 | 103 | 28 | 4 | int:EFNA1 | |
| Interaction | ABL2 interactions | 1.39e-05 | 107 | 28 | 4 | int:ABL2 | |
| Interaction | PLEKHA1 interactions | 1.45e-05 | 108 | 28 | 4 | int:PLEKHA1 | |
| Interaction | USP6NL interactions | 1.56e-05 | 110 | 28 | 4 | int:USP6NL | |
| Interaction | PIK3R1 interactions | 1.81e-05 | 412 | 28 | 6 | int:PIK3R1 | |
| Interaction | TNS1 interactions | 2.47e-05 | 41 | 28 | 3 | int:TNS1 | |
| Interaction | TNS4 interactions | 3.06e-05 | 44 | 28 | 3 | int:TNS4 | |
| Interaction | NTPCR interactions | 3.58e-05 | 136 | 28 | 4 | int:NTPCR | |
| Interaction | ARHGAP32 interactions | 5.12e-05 | 149 | 28 | 4 | int:ARHGAP32 | |
| Interaction | HSPA1B interactions | 5.33e-05 | 301 | 28 | 5 | int:HSPA1B | |
| Interaction | CYFIP1 interactions | 5.50e-05 | 303 | 28 | 5 | int:CYFIP1 | |
| Interaction | GOPC interactions | 5.50e-05 | 303 | 28 | 5 | int:GOPC | |
| Interaction | SH3KBP1 interactions | 6.61e-05 | 315 | 28 | 5 | int:SH3KBP1 | |
| Interaction | SHE interactions | 6.66e-05 | 9 | 28 | 2 | int:SHE | |
| Interaction | NISCH interactions | 6.75e-05 | 160 | 28 | 4 | int:NISCH | |
| Interaction | HGS interactions | 6.88e-05 | 523 | 28 | 6 | int:HGS | |
| Interaction | CYFIP2 interactions | 7.44e-05 | 323 | 28 | 5 | int:CYFIP2 | |
| Interaction | CAMK2N1 interactions | 8.32e-05 | 10 | 28 | 2 | int:CAMK2N1 | |
| Interaction | GRB2 interactions | 9.04e-05 | 806 | 28 | 7 | int:GRB2 | |
| Interaction | CALM3 interactions | 9.88e-05 | 343 | 28 | 5 | int:CALM3 | |
| Interaction | CDCA3 interactions | 9.99e-05 | 177 | 28 | 4 | int:CDCA3 | |
| Interaction | LSR interactions | 9.99e-05 | 177 | 28 | 4 | int:LSR | |
| Interaction | SEPTIN3 interactions | 1.04e-04 | 66 | 28 | 3 | int:SEPTIN3 | |
| Interaction | EFNA5 interactions | 1.13e-04 | 68 | 28 | 3 | int:EFNA5 | |
| Interaction | MYCBP2 interactions | 1.16e-04 | 355 | 28 | 5 | int:MYCBP2 | |
| Interaction | SHC3 interactions | 1.34e-04 | 72 | 28 | 3 | int:SHC3 | |
| Interaction | NLRP10 interactions | 1.44e-04 | 13 | 28 | 2 | int:NLRP10 | |
| Interaction | IL6ST interactions | 1.46e-04 | 74 | 28 | 3 | int:IL6ST | |
| Interaction | DIP2B interactions | 1.52e-04 | 75 | 28 | 3 | int:DIP2B | |
| Interaction | RAC3 interactions | 1.73e-04 | 619 | 28 | 6 | int:RAC3 | |
| Interaction | TBCK interactions | 1.98e-04 | 82 | 28 | 3 | int:TBCK | |
| Interaction | STYX interactions | 2.12e-04 | 84 | 28 | 3 | int:STYX | |
| Interaction | SHB interactions | 2.12e-04 | 84 | 28 | 3 | int:SHB | |
| Interaction | UNC5B interactions | 2.12e-04 | 84 | 28 | 3 | int:UNC5B | |
| Interaction | CDC37 interactions | 2.17e-04 | 645 | 28 | 6 | int:CDC37 | |
| Interaction | NCKAP1 interactions | 2.22e-04 | 218 | 28 | 4 | int:NCKAP1 | |
| Interaction | SEC24A interactions | 2.47e-04 | 224 | 28 | 4 | int:SEC24A | |
| Interaction | WNT7B interactions | 2.50e-04 | 17 | 28 | 2 | int:WNT7B | |
| Interaction | PKP2 interactions | 2.51e-04 | 225 | 28 | 4 | int:PKP2 | |
| Interaction | PIK3R2 interactions | 2.73e-04 | 230 | 28 | 4 | int:PIK3R2 | |
| Interaction | PLEKHA5 interactions | 2.77e-04 | 231 | 28 | 4 | int:PLEKHA5 | |
| Interaction | YKT6 interactions | 2.96e-04 | 235 | 28 | 4 | int:YKT6 | |
| Interaction | NF1 interactions | 3.11e-04 | 238 | 28 | 4 | int:NF1 | |
| Interaction | KALRN interactions | 3.15e-04 | 96 | 28 | 3 | int:KALRN | |
| Interaction | VAV2 interactions | 3.45e-04 | 99 | 28 | 3 | int:VAV2 | |
| Interaction | OPRL1 interactions | 3.76e-04 | 102 | 28 | 3 | int:OPRL1 | |
| Interaction | MAP4K5 interactions | 3.76e-04 | 102 | 28 | 3 | int:MAP4K5 | |
| Interaction | ZFYVE16 interactions | 3.98e-04 | 104 | 28 | 3 | int:ZFYVE16 | |
| Interaction | MB21D2 interactions | 3.98e-04 | 104 | 28 | 3 | int:MB21D2 | |
| Interaction | CAV1 interactions | 4.03e-04 | 724 | 28 | 6 | int:CAV1 | |
| Interaction | SEC23A interactions | 4.04e-04 | 255 | 28 | 4 | int:SEC23A | |
| Interaction | GRID1 interactions | 4.23e-04 | 22 | 28 | 2 | int:GRID1 | |
| Interaction | SHC4 interactions | 4.23e-04 | 22 | 28 | 2 | int:SHC4 | |
| Interaction | ACBD3 interactions | 4.28e-04 | 259 | 28 | 4 | int:ACBD3 | |
| Interaction | FCHO2 interactions | 4.57e-04 | 109 | 28 | 3 | int:FCHO2 | |
| Interaction | PLCG1 interactions | 4.60e-04 | 264 | 28 | 4 | int:PLCG1 | |
| Interaction | ERBIN interactions | 4.67e-04 | 265 | 28 | 4 | int:ERBIN | |
| Interaction | SPAG6 interactions | 5.48e-04 | 25 | 28 | 2 | int:SPAG6 | |
| Interaction | MOSPD3 interactions | 5.48e-04 | 25 | 28 | 2 | int:MOSPD3 | |
| Interaction | HSH2D interactions | 5.48e-04 | 25 | 28 | 2 | int:HSH2D | |
| Interaction | IFITM3 interactions | 6.34e-04 | 513 | 28 | 5 | int:IFITM3 | |
| Interaction | RIMS2 interactions | 6.39e-04 | 27 | 28 | 2 | int:RIMS2 | |
| Interaction | STAP1 interactions | 6.39e-04 | 27 | 28 | 2 | int:STAP1 | |
| Interaction | BRK1 interactions | 6.66e-04 | 124 | 28 | 3 | int:BRK1 | |
| Interaction | RAB11FIP1 interactions | 6.81e-04 | 125 | 28 | 3 | int:RAB11FIP1 | |
| Interaction | SLC22A6 interactions | 6.88e-04 | 28 | 28 | 2 | int:SLC22A6 | |
| Interaction | BAIAP2L1 interactions | 7.47e-04 | 129 | 28 | 3 | int:BAIAP2L1 | |
| Interaction | SOCS6 interactions | 7.64e-04 | 130 | 28 | 3 | int:SOCS6 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.63e-09 | 14 | 22 | 4 | 1095 | |
| GeneFamily | Sterile alpha motif domain containing | 6.01e-08 | 88 | 22 | 5 | 760 | |
| GeneFamily | Fibronectin type III domain containing | 3.82e-05 | 160 | 22 | 4 | 555 | |
| GeneFamily | MAGE family | 1.07e-03 | 40 | 22 | 2 | 1136 | |
| GeneFamily | Solute carriers | 1.17e-02 | 395 | 22 | 3 | 752 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-06 | 191 | 28 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-06 | 193 | 28 | 4 | 9f9eb241b0b82a6f12de6921c3acf6fed7cf65bb | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 195 | 28 | 4 | d32716a12014522492becbde1088dc1106308490 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 195 | 28 | 4 | b913d5df50c88a3a255f516a1aa42419c6701e1e | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.16e-05 | 129 | 28 | 3 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.12e-05 | 140 | 28 | 3 | 5623a0a68403fc00166b7d13d13e184a718d9bdd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 147 | 28 | 3 | 64fa0753a3a79f492ef8acc6942bf90d379a983f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 148 | 28 | 3 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 148 | 28 | 3 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.10e-04 | 149 | 28 | 3 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 155 | 28 | 3 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 157 | 28 | 3 | 6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-04 | 160 | 28 | 3 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 161 | 28 | 3 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 1.38e-04 | 161 | 28 | 3 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-04 | 166 | 28 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 167 | 28 | 3 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 167 | 28 | 3 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 1.59e-04 | 169 | 28 | 3 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | facs-Skin-nan-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 172 | 28 | 3 | 5ca89af7406e7e1a055dd60d6f89615f69e62324 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 174 | 28 | 3 | b2fc2a756f8e373ad903bd416d9de703d945fa1c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 176 | 28 | 3 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-04 | 178 | 28 | 3 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-04 | 179 | 28 | 3 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.89e-04 | 179 | 28 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 180 | 28 | 3 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 181 | 28 | 3 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 182 | 28 | 3 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.98e-04 | 182 | 28 | 3 | 69b5cae6fe3bbb0fc60bd2f71b6cfa6cbb0b00ee | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 183 | 28 | 3 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 2.01e-04 | 183 | 28 | 3 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 183 | 28 | 3 | 738e94b50c4c08c727d4eed0708dda08aa6891b4 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 183 | 28 | 3 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 183 | 28 | 3 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-04 | 183 | 28 | 3 | f6ebfd7f61e912f92bd07313cc213a171747ac03 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 2.11e-04 | 186 | 28 | 3 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 186 | 28 | 3 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 28 | 3 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 28 | 3 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 187 | 28 | 3 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 187 | 28 | 3 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 188 | 28 | 3 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.21e-04 | 189 | 28 | 3 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 189 | 28 | 3 | c9565e962a13a7713056ec3dbb1b67d24f9889c7 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-04 | 189 | 28 | 3 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 189 | 28 | 3 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 189 | 28 | 3 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-04 | 189 | 28 | 3 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.25e-04 | 190 | 28 | 3 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 190 | 28 | 3 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 191 | 28 | 3 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.28e-04 | 191 | 28 | 3 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-04 | 191 | 28 | 3 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.32e-04 | 192 | 28 | 3 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 192 | 28 | 3 | fd08ae787e936cfdb1ab8f19b0fd63005b462709 | |
| ToppCell | Control-Treg|Control / Disease group and Cell class | 2.32e-04 | 192 | 28 | 3 | 3a9a8ac2aa278adde848608f9bb92a002dbb9bcc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 192 | 28 | 3 | bae236c9f1fac77bce28d0a9cf090100d391ff77 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.39e-04 | 194 | 28 | 3 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.39e-04 | 194 | 28 | 3 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-04 | 194 | 28 | 3 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.39e-04 | 194 | 28 | 3 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.39e-04 | 194 | 28 | 3 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.42e-04 | 195 | 28 | 3 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.42e-04 | 195 | 28 | 3 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | T_cells-Treg_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.50e-04 | 197 | 28 | 3 | de5448fcdf4e433fc167496413abe5d0c8a5c6d8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 2.50e-04 | 197 | 28 | 3 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.50e-04 | 197 | 28 | 3 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.54e-04 | 198 | 28 | 3 | a6f65bb0845d8f64f5c7edb00cee3ca5adb1a373 | |
| ToppCell | Sigmoid-T_cell-Treg|T_cell / Region, Cell class and subclass | 2.54e-04 | 198 | 28 | 3 | e2d2f9f209f77d0c48cfe3e9902c0ae0795511b2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 198 | 28 | 3 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.54e-04 | 198 | 28 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.57e-04 | 199 | 28 | 3 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Sigmoid-T_cell-Treg|Sigmoid / Region, Cell class and subclass | 2.57e-04 | 199 | 28 | 3 | 972f1306a38aab0ac9df97df67b28a38b6a05606 | |
| ToppCell | Sigmoid-(1)_T_cell-(15)_Treg|Sigmoid / shred on region, Cell_type, and subtype | 2.57e-04 | 199 | 28 | 3 | 0b736634aaac5759776cb8a0110b1f065b486b5f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 200 | 28 | 3 | f0c338877e39226a90c4effe12f6501d33542a73 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 28 | 3 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| Computational | Genes in the cancer module 80. | 2.25e-05 | 32 | 19 | 3 | MODULE_80 | |
| Computational | Porins / transporters. | 2.58e-05 | 211 | 19 | 5 | MODULE_63 | |
| Computational | Genes in the cancer module 51. | 3.22e-05 | 36 | 19 | 3 | MODULE_51 | |
| Computational | Genes in the cancer module 85. | 9.24e-05 | 51 | 19 | 3 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 1.29e-04 | 57 | 19 | 3 | MODULE_199 | |
| Computational | Genes in the cancer module 27. | 3.03e-04 | 355 | 19 | 5 | MODULE_27 | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.29e-07 | 198 | 28 | 6 | 5476_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; HL60; HT_HG-U133A | 3.23e-06 | 190 | 28 | 5 | 6156_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.85e-06 | 197 | 28 | 5 | 4803_UP | |
| Drug | AC1NDVEB | 4.54e-06 | 91 | 28 | 4 | CID004632235 | |
| Drug | AR 12465 | 8.74e-06 | 4 | 28 | 2 | CID000127645 | |
| Drug | TAK-165 | 1.46e-05 | 5 | 28 | 2 | CID006444692 | |
| Drug | Linuron | 1.76e-05 | 128 | 28 | 4 | ctd:D008044 | |
| Drug | Naphthols | 2.18e-05 | 6 | 28 | 2 | ctd:D009284 | |
| Drug | procymidone | 3.72e-05 | 155 | 28 | 4 | ctd:C035988 | |
| Drug | class IC | 3.74e-05 | 53 | 28 | 3 | CID000056160 | |
| Drug | 5 alpha-cholest-8(14)-en-3 beta-ol-15-one | 4.07e-05 | 8 | 28 | 2 | CID000039756 | |
| Drug | 5-(4-((6-(allyloxy)-2,5,7,8-tetramethylchroman-2-yl)methoxy)-3-methoxybenzylidene)thiazolidine-2,4-dione | 4.07e-05 | 8 | 28 | 2 | ctd:C513003 | |
| Drug | NSC624746 | 4.66e-05 | 57 | 28 | 3 | CID000107640 | |
| Drug | epoxiconazole | 5.42e-05 | 341 | 28 | 5 | ctd:C109476 | |
| Drug | BIRB796 | 7.24e-05 | 66 | 28 | 3 | CID000156422 | |
| Drug | ponatinib | 7.91e-05 | 68 | 28 | 3 | ctd:C545373 | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.22e-05 | 190 | 28 | 4 | 6274_DN | |
| Drug | SB-C | 8.27e-05 | 69 | 28 | 3 | CID005331010 | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 8.39e-05 | 191 | 28 | 4 | 7507_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 4653_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 2223_DN | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A | 9.09e-05 | 195 | 28 | 4 | 6510_DN | |
| Drug | Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 2922_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 6898_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 7155_UP | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 6445_DN | |
| Drug | Aminophylline [317-34-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 6295_DN | |
| Drug | CAY10397; Up 200; 10uM; PC3; HT_HG-U133A | 9.28e-05 | 196 | 28 | 4 | 7071_UP | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 6350_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; PC3; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 2074_UP | |
| Drug | D-cycloserine [68-41-7]; Up 200; 39.2uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 3562_UP | |
| Drug | Procaine hydrochloride [51-05-8]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 1674_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 2262_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 9.46e-05 | 197 | 28 | 4 | 4100_UP | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 5110_DN | |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; HL60; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 3134_UP | |
| Drug | Zaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 9.84e-05 | 199 | 28 | 4 | 3226_UP | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A | 9.84e-05 | 199 | 28 | 4 | 6560_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HT_HG-U133A | 9.84e-05 | 199 | 28 | 4 | 4637_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 9.84e-05 | 199 | 28 | 4 | 7219_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 5782_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 200 | 28 | 4 | 3182_UP | |
| Drug | Cocaine | 1.32e-04 | 1314 | 28 | 8 | ctd:D003042 | |
| Drug | diethyl malate | 1.59e-04 | 86 | 28 | 3 | ctd:C058705 | |
| Drug | estradiol 3-benzoate | 1.76e-04 | 89 | 28 | 3 | ctd:C074283 | |
| Drug | Lithocholic Acid | 2.02e-04 | 240 | 28 | 4 | ctd:D008095 | |
| Drug | vandetanib | 2.41e-04 | 99 | 28 | 3 | CID003081361 | |
| Drug | polycyclic musk | 2.46e-04 | 19 | 28 | 2 | CID000006930 | |
| Drug | 2,2',4,6,6'-pentachlorobiphenyl | 2.73e-04 | 20 | 28 | 2 | ctd:C417207 | |
| Drug | Heptachlor Epoxide | 2.79e-04 | 104 | 28 | 3 | ctd:D006534 | |
| Drug | prochloraz | 3.08e-04 | 268 | 28 | 4 | ctd:C045362 | |
| Drug | oxandrolone | 3.63e-04 | 23 | 28 | 2 | CID000005878 | |
| Drug | trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 3.96e-04 | 24 | 28 | 2 | ctd:D001371 | |
| Drug | difenoconazole | 4.30e-04 | 25 | 28 | 2 | ctd:C115058 | |
| Drug | Arsenates | 4.46e-04 | 122 | 28 | 3 | ctd:D001149 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 4.83e-04 | 302 | 28 | 4 | ctd:D003633 | |
| Drug | enzacamene | 5.25e-04 | 129 | 28 | 3 | ctd:C038939 | |
| Drug | sunitinib | 5.37e-04 | 130 | 28 | 3 | CID005329102 | |
| Drug | DMAB | 5.74e-04 | 133 | 28 | 3 | CID000006053 | |
| Drug | docetaxel | 5.74e-04 | 133 | 28 | 3 | ctd:C067311 | |
| Drug | ML-236A | 5.86e-04 | 134 | 28 | 3 | CID000173651 | |
| Drug | NPC 12626 | 6.63e-04 | 31 | 28 | 2 | CID000108099 | |
| Drug | o,p'-DDE | 7.07e-04 | 32 | 28 | 2 | CID000246598 | |
| Drug | glutamic acid diethyl ester | 8.95e-04 | 36 | 28 | 2 | CID000073960 | |
| Drug | butylparaben | 9.28e-04 | 157 | 28 | 3 | ctd:C038091 | |
| Drug | sorafenib | 9.46e-04 | 158 | 28 | 3 | CID000216239 | |
| Drug | anastrozole | 9.46e-04 | 37 | 28 | 2 | CID000002187 | |
| Drug | glutamate | 9.49e-04 | 962 | 28 | 6 | CID000000611 | |
| Drug | 2-cyanoacetamide | 1.02e-03 | 162 | 28 | 3 | CID000007898 | |
| Drug | 11-[(2S,3R)-3-amyloxiran-2-yl]undecanoic acid | 1.05e-03 | 39 | 28 | 2 | CID011022912 | |
| Drug | ginsenoside Rg3 | 1.05e-03 | 39 | 28 | 2 | ctd:C097367 | |
| Drug | N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide | 1.05e-03 | 39 | 28 | 2 | ctd:C078131 | |
| Drug | DB04790 | 1.11e-03 | 40 | 28 | 2 | CID005326924 | |
| Drug | m262 | 1.22e-03 | 42 | 28 | 2 | CID000009012 | |
| Disease | Adenocarcinoma of prostate | 8.63e-07 | 20 | 28 | 3 | C0007112 | |
| Disease | temporal lobe epilepsy (is_marker_for) | 1.63e-04 | 20 | 28 | 2 | DOID:3328 (is_marker_for) | |
| Disease | Colorectal Carcinoma | 4.69e-04 | 702 | 28 | 5 | C0009402 | |
| Disease | Spinocerebellar Ataxia Type 2 | 4.78e-04 | 34 | 28 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 4.78e-04 | 34 | 28 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 4.78e-04 | 34 | 28 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 4.78e-04 | 34 | 28 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 4.78e-04 | 34 | 28 | 2 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 4.78e-04 | 34 | 28 | 2 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 4 | 5.07e-04 | 35 | 28 | 2 | C0752122 | |
| Disease | body weights and measures | 5.98e-04 | 38 | 28 | 2 | EFO_0004324 | |
| Disease | Neoplasm Recurrence, Local | 6.30e-04 | 39 | 28 | 2 | C0027643 | |
| Disease | cholesteryl ester 20:5 measurement | 8.01e-04 | 44 | 28 | 2 | EFO_0010349 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SMMLFDTFLYGVMTW | 826 | O95477 | |
| YVMMIYFDMEVWALG | 331 | Q9NW15 | |
| VQAWLEVVMAMPMYV | 451 | Q674X7 | |
| IWEALNMMGLYDGME | 246 | P43363 | |
| EEAVWEIMNMMGVYA | 216 | Q96M61 | |
| FLGSIMWIAMFSYLM | 941 | O60721 | |
| AMLVTMFGWFAMVIA | 206 | Q9BY71 | |
| MWEVMSYGERPYWDM | 816 | P29323 | |
| YMMFEVMEPTWHILE | 696 | Q9BSJ2 | |
| AVIQYSWMGLMVFAM | 736 | P10275 | |
| MWEVMSYGERPYWDM | 826 | Q15375 | |
| RMSGIYWGLTVMDLM | 46 | P53611 | |
| YLLMGEMHMVDTVTW | 106 | Q9H237 | |
| IDVYMIMVKCWMIDA | 941 | P00533 | |
| FRFYWDLIMLIMMVG | 141 | O60741 | |
| MDSYLLMWGLLTFIM | 1 | P01589 | |
| MAMDEYLWMVILGFI | 1 | Q08357 | |
| VRWMMYWIVFALFMA | 36 | Q9H6H4 | |
| MWEVMSYGERPYWEM | 866 | Q9UF33 | |
| MAASLWMGDLEPYMD | 1 | Q9NX07 | |
| MWEVMSYGERPYWDM | 851 | O15197 | |
| GMDMMVYVWTLSDPE | 551 | O75083 | |
| YLLRPMVFMMGVEWT | 461 | O43868 | |
| PEYRRITLMMMGVWF | 441 | Q7L0J3 | |
| LWMAMVISSFDMVIY | 351 | Q8WUD6 | |
| ELVKTLGFDWIMMFM | 1661 | Q8IZQ1 | |
| VFQDLLYLMDWMEEM | 536 | O15020 | |
| LEPFSADVWVMMFVM | 551 | Q13224 |